Join us at year end as we learn & celebrate the latest advancements made during 2025!
Your speakers already include the below.
All providing 3D research insights from across their companies & institutions.
Keynote. Professor Martin Knight, CPM, QMUL.
AstraZeneca: Dr Carol de Santis, Clinical Pharmacology & Safety.
Cardiff University: Dr Luned Badder, School of Medicine.
Cosyne Therapeutics: Dr Julia Kleniuk & Dr Zoe Smith.
GSK: Dr Lisa Mohamet, Target Discovery.
Imperial College London: Dr Tamas Korcsmaros.
University of Oxford: Dr Abdullah Khan.
Early Career Talk. Corinne Molyneux, UCL. A single-cell co-culture CRISPR screening platform to perturb the intercellular communication between cancer associated fibroblasts and the colorectal cancer epithelia.
A wonderful day for all! Tickets include; attendance, lunch, refreshments and the Xmas social from 4-6pm.
Main sponsors:
Qkine. Raising the standard in bioactive protein manufacturing and innovation.
Key note speakers
Dr Carol de Santis
Cardiovascular Safety expert | MPS and Advanced in-vitro models | Senior Safety Scientist at AstraZeneca
Dr Luned Badder
School of Medicine, Cardiff University. Working with organoids and precision virotherapies
Dr Julia Kleniuk
Dr Zoe Smith
Experimental Biologist
CoSyne Therapeutics
Dr Lisa
Mohamet
Global Head Translational In Vitro Models, Functional Genomics at GSK
Dr Tamas Korcsmaros
KorcsmarosLab & Imperial College London Organoid Facility
Dr Abdullah
Khan
Corinne
Molyneux
EARLY CAREER SPEAKER:
Studying Cancer Biology at UCL
Location: Queens' building
QMUL, Queens' Building, 327 Mile End Rd, London E1 4NS
Enter the summer code of 'Feelinghothothot' to save 15% for a limited time!
